Latest news
Wedbush Adjusts PT on Praxis Precision Medicines to $188 From $162, Maintains Underperform Rating - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 16:05:51 GMTWHR Maintains Rating by RBC Capital -- Price Target Raised to $3 - GuruFocusGuruFocus · Wed, 05 Aug 2026 19:34:15 GMTBNP Paribas Adjusts Price Target on Global Payments to $70 From $60, Maintains Underperform Rating - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 18:17:23 GMTBNP Paribas Adjusts Alexandria Real Estate Equities PT to $48 From $45, Maintains Underperform Rating - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 13:32:19 GMTRBC Capital Adjusts Price Target on Whirlpool to $32 From $30, Maintains Underperform Rating - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 13:25:01 GMTEvercore ISI Adjusts Price Target on Clorox to $99 From $98, Maintains Underperform Rating - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 10:42:41 GMTJefferies Adjusts PT on Palantir Technologies to $80 From $70, Maintains Underperform Rating - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 09:48:04 GMTBNP Paribas Adjusts Johnson Controls International PT to $130 From $120, Maintains Underperform Rating - MoomooMoomoo · Fri, 31 Jul 2026 14:16:03 GMT